- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 31/20 - Antivirals for DNA viruses
Patent holdings for IPC class A61P 31/20
Total number of patents in this class: 2723
10-year publication summary
|
74
|
82
|
100
|
181
|
241
|
307
|
326
|
332
|
293
|
55
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mondobiotech Laboratories AG | 311 |
105 |
| Hoffmann-La Roche Inc. | 3060 |
98 |
| Janssen Sciences Ireland Unlimited Company | 431 |
90 |
| Aligos Therapeutics, Inc. | 129 |
57 |
| F. Hoffmann-La Roche AG | 7958 |
55 |
| Gilead Sciences, Inc. | 1879 |
49 |
| Arbutus Biopharma Corporation | 183 |
31 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 616 |
29 |
| Sunshine Lake Pharma Co., Ltd. | 542 |
27 |
| Xiamen University | 488 |
24 |
| Assembly Biosciences, Inc. | 66 |
19 |
| VIR Biotechnology, Inc. | 114 |
18 |
| Emory University | 1498 |
17 |
| Glaxosmithkline Biologicals S.A. | 1701 |
16 |
| Enanta Pharmaceuticals, Inc. | 420 |
15 |
| Intervet International B.V. | 1235 |
15 |
| Boehringer Ingelheim Animal Health USA Inc. | 507 |
15 |
| Novartis AG | 11238 |
14 |
| The Regents of the University of California | 18943 |
13 |
| Intervet Inc. | 848 |
13 |
| Other owners | 2003 |